| Page No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 |
| Phrase | Consultant | Town | Special Interests |
| Chemical Pathology | *Consultant(s)* | *Towns* | Metabolic medicine |
| Chemical Pathology | *Consultant(s)* | *Towns* | Lipid disorders, assessment of renal function, clinical informatics, point of care testing |
| Chemical Pathology | *Consultant(s)* | *Towns* | Forensic toxicology, clinical nutrition |
| Chemical Pathology | *Consultant(s)* | *Towns* | Inherited hyperlipidaemia, familial hypercholesterolaemia, lipid abnormalities associated with hiv treatment, management of severe hypertriglyceridaemia, management of cardiovascular disease risk in people of Indian origin, cardiac biomarkers, cardiovascular disease screening in hard to reach communities |
| Chemical Pathology | *Consultant(s)* | *Towns* | Metabolic medicine, lipids and cardiovascular disease, metabolic bone disease |
| Chemical Pathology | *Consultant(s)* | *Towns* | Metabolic medicine |
| Chemical Pathology | *Consultant(s)* | *Towns* | Clinical interests in diabetes, lipids, TPN - total parenteral nutrition, laboratory interests in trace elements, TDM - therapeutic drug monitoring, proteins |
| Chemical Pathology | *Consultant(s)* | *Towns* | Type 2 diabetes, inherited lipid disorders, endocrinology |
| Chemical Pathology | *Consultant(s)* | *Towns* | Lipidology, metabolic bone diseases, toxicology |
| Chemical Pathology | *Consultant(s)* | *Towns* | Metabolic medicine, lipidology, obesity |
| Chemical Pathology | *Consultant(s)* | *Towns* | Metabolic bone diseases, lipid disorders, osteoporosis |
| Chemical Pathology | *Consultant(s)* | *Towns* | Metabolic medicine |
| Chemical Pathology | *Consultant(s)* | *Towns* | Cardiovascular risk factors, lipids and obesity, renal stones |
| Chemical Pathology | *Consultant(s)* | *Towns* | Lipid disorders |
| Chemical pathology | *Consultant(s)* | *Towns* | Chemical pathology |
| Chemical Pathology | *Consultant(s)* | *Towns* | Metabolic medicine, metabolic bone disease and osteoporosis, cardiovascular risk and lipid management |
| Chemical Pathology | *Consultant(s)* | *Towns* | Metabolic medicine |
| Chemical pathology | *Consultant(s)* | *Towns* | Chemical pathology, obesity, lipid disorders, metabolic bone disease, alkaptonuria |
| Chemical Pathology | *Consultant(s)* | *Towns* | Hyperlipidaemia, renal stones, screening, antenatal Down's screening, obesity |
| Chemical Pathology | *Consultant(s)* | *Towns* | Metabolic medicine |
| Chemical Pathology | *Consultant(s)* | *Towns* | Biochemistry |
| Chemical Pathology | *Consultant(s)* | *Towns* | Metabolic medicine, obesity |
| Chemical Pathology | *Consultant(s)* | *Towns* | Medical biochemistry, metabolic medicine |
| Chemical Pathology | *Consultant(s)* | *Towns* | Metabolic medicine, inherited metabolic disorders |
| Chemical Pathology | *Consultant(s)* | *Towns* | Lipidology, diabetes, nutrition, clinical chemistry |
| Chemical Pathology | *Consultant(s)* | *Towns* | Obesity, lipid disorders |
| Chemical Pathology | *Consultant(s)* | *Towns* | Diabetes and endocrinology, metabolic medicine |
| Chemical Pathology | *Consultant(s)* | *Towns* | Dyslipidaemia, obesity, diabetes/metabolic syndrome, renal stones |
| Chemical Pathology | *Consultant(s)* | *Towns* | Endocrinology, lipids, thyroid disease, polycystic ovaries disease, neuroendocrine tumours |
| Chemical Pathology | *Consultant(s)* | *Towns* | Metabolic medicine |
| Chemical Pathology | *Consultant(s)* | *Towns* | Metabolic medicine, obesity, lipid disorders |
| Chemical Pathology | *Consultant(s)* | *Towns* | Metabolic medicine, renal stones, lipids, clinical biochemistry |
| Chemical Pathology | *Consultant(s)* | *Towns* | Metabolic medicine |
| Chemical Pathology | *Consultant(s)* | *Towns* | Biochemistry |
| Chemical Pathology | *Consultant(s)* | *Towns* | Preventive cardiology, lipidology, metabolic disorders, renal stones |
| Chemical Pathology | *Consultant(s)* | *Towns* | Lipidology, obesity and bariatric medicine, thyroid disorders and surgery, parenteral nutrition, endocrine disorders and surgery, metabolic medicine |
| Chemical Pathology | *Consultant(s)* | *Towns* | Metabolic medicine |
| Chemical Pathology | *Consultant(s)* | *Towns* | Clinical chemistry, paediatric pathology, inborn errors |
| Chemical pathology | *Consultant(s)* | *Towns* | Chemical pathology, lipid disorders, cardiovascular prevention, adult inherited errors of metabolism - peroxisome |
| Chemical Pathology | *Consultant(s)* | *Towns* | Lipids, obesity, metabolic syndrome |
| Chemical Pathology | *Consultant(s)* | *Towns* | Adult inherited metabolic disorders |
| Chemical pathology | *Consultant(s)* | *Towns* | Chemical pathology, lipidology |
| Chemical Pathology | *Consultant(s)* | *Towns* | Lipids |
| Chemical pathology and laboratory medicine | *Consultant(s)* | *Towns* | Chemical pathology and laboratory medicine, lipids and cardiovascular risk, metabolic medicine, endocrinology |
| children's ENT pathology | *Consultant(s)* | *Towns* | Rhinitis, deafness post trauma, paediatric ENT, voice, smell and taste post trauma, imbalance post trauma, nose and sinus diseases, chronic cough, voice and swallowing problems, cosmetic rhinoplasty, snoring, children's ENT pathology, noise induced hearing loss |
| Clinical Director Pathology | *Consultant(s)* | *Towns* | Breast, skin, Clinical Director Pathology, Haematology and Oncology |
| Colon cancer pathology | *Consultant(s)* | *Towns* | Colon cancer pathology, cytology |
| Colorectal cancer pathology | *Consultant(s)* | *Towns* | Colorectal cancer pathology |
| colorectal cancer pathology | *Consultant(s)* | *Towns* | Gastrointestinal pathology, uropathology, colorectal cancer pathology |
| colorectal cancer pathology | *Consultant(s)* | *Towns* | Lung cancer pathology, colorectal cancer pathology |
| Page No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 |
